BCYC
BICYCLE THERAPEUTICS PLC
Key Financials
Operating Income
$-247065000
↓ 17.7%
Net Income
$-218960000
↓ 29.5%
EPS (Diluted)
$-3.16
↓ 9.0%
Total Liabilities
$107.6M
↓ 34.3%
Total Assets
$717.6M
↓ 25.0%
Cash & Equivalents
$628.1M
↓ 28.6%
Revenue
$72.6M
↑ 105.8%
Shareholders' Equity
$610.0M
↓ 23.1%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G/A | 5/15/2026 | View on SEC |
| SCHEDULE 13G | 5/15/2026 | View on SEC |
| SCHEDULE 13G/A | 5/4/2026 | View on SEC |
| 10-Q | 4/30/2026 | View on SEC |
| 8-K | 4/30/2026 | View on SEC |
| ARS | 4/22/2026 | View on SEC |
| DEF 14A | 4/22/2026 | View on SEC |
| 8-K | 4/20/2026 | View on SEC |
| 4 | 4/6/2026 | View on SEC |
| 4 | 4/6/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | BCYC |
| Company Name | BICYCLE THERAPEUTICS PLC |
| CIK | 1761612 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | X0 |
| Phone | 011441223261503 |